SCHEMBL8537628

SCHEMBL8537628

C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C(c5ccc(-c6ccc(C#N)cc6)cc5)C[C@@H]43)[C@@H]1CC[C@@]2(O)/C=C\CO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 2/20 0.40
▸ PDK2 Q15119 2/20 0.40
▸ PDK3 Q15120 2/20 0.40
▸ PDK4 Q16654 2/20 0.40
▸ ESR1 P03372 6/20 0.38
▸ NR3C1 P04150 4/20 0.38
▸ PGR P06401 4/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ ABCB11 O95342 3/20 0.38
▸ LMNA P02545 3/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ SLC6A4 P31645 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ SHBG P04278 1/20 0.38
▸ ADRA2A P08913 1/20 0.38
▸ AR P10275 3/20 0.34
▸ CHRM2 P08172 3/20 0.34
▸ SLC6A2 P23975 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8536672 0.88 PDK1 (0.38) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8541984 0.87 PDK1 (0.37) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8541599 0.87 PDK1 (0.37) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8536109 0.86 NR3C1 (0.40) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8542556 0.86 NR3C1 (0.40) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8536623 0.86 PGR (0.39) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8536985 0.85 PDK1 (0.37) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8541378 0.85 PDK1 (0.39) PDK1PDK2PDK3PDK4ESR1
SCHEMBL8623179 0.83 PGR (0.34) PGRARNR3C2
SCHEMBL8536675 0.79 PGR (0.50) ESR1NR3C1PGRCYP3A4ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843933-A 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1998-12-01 — — US disclosed
US-5728689-A ANTIGESTAGENIC EFFECT SCHERING AKTIENGESELLSCHAFT (DE) 1998-03-17 — — US disclosed
Send feedback